申请人:Heptares Therapeutics Limited
公开号:US20150126498A1
公开(公告)日:2015-05-07
The disclosures herein relate to novel compounds of formula wherein W, X and Y
1
, Y
2
, Y
3
and Y
4
are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of neurological or psychiatric disorders associated with orexin receptors.
本文披露了一种公式化合物,其中W、X和Y1、Y2、Y3和Y4在此定义,并且它们在治疗、预防、改善、控制或降低与促进素受体相关的神经或精神障碍的风险方面的使用。